Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization

Pediatric Infectious Disease Journal

Volumn 19, Issue 8, 2000, Pages 757-759

  Von König, Carl Heinz Wirsing ^a,e   Herden, Peter ^b   Palitzsch, Dieter ^c   Schneeweiss, Burghard ^d   Bier, Norbert ^c  

^a Klinikum Krefeld   (Germany)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

^d VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^e HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

Acellular vaccines; Immunogenicity; Pertussis; Primary vaccination

Indexed keywords

ACELIMMUNE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; PERTUSSIS VACCINE; REFERENCE VALUES; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 0033883437     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200008000-00018     Document Type: Article

References (10)

1. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children: Recommendations of the Advisory Committee in Immunization Practices (ACIP)
2. Comparative efficacy of acellular pertussis vaccines: An analysis of recent trials
3. Comparison of 13 acellular pertussis vaccines: Overview and serologic response
4. Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine
5. Comparison of 13 acellular pertussis vaccines: Adverse reactions
6. Serological correlates of immunity to Bordetella pertussis
7. A search for serologic correlates of immunity to Bordetella pertussis coughing illness
8. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
9. A randomized clinical trial of acellular pertussis vaccines in healthy adults: Dose-response comparison of 5 vaccines and implications for booster vaccination
10. Evaluation of the interchangeability of two different diphtheria-tetanusacellular pertussis vaccines administered to healthy infants at 2, 4, and 6 months of age